These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10561327)

  • 21. Post-ischemic RSR13 amplifies the effect of dizocilpine on outcome from transient focal cerebral ischemia in the rat.
    Mackensen GB; Nellgård B; Sarraf-Yazdi S; Dexter F; Steffen RP; Grocott HP; Warner DS
    Brain Res; 2000 Jan; 853(1):15-21. PubMed ID: 10627303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of RSR13 on temperature-dependent changes in hemoglobin oxygen affinity of human whole blood.
    Steffen RP
    Adv Exp Med Biol; 1998; 454():653-61. PubMed ID: 9889946
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of FI(O(2)) on hemodynamic responses and O(2) transport during RSR13-induced reduction in P(50).
    Eichelbrönner O; Sielenkämper A; D'Almeida M; Ellis CG; Sibbald WJ; Chin-Yee IH
    Am J Physiol; 1999 Jul; 277(1):H290-8. PubMed ID: 10409208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiforme.
    Mikkelsen T; Lush R; Grossman SA; Carson KA; Fisher JD; Alavi JB; Rosenfeld S
    Invest New Drugs; 2007 Jun; 25(3):259-63. PubMed ID: 17080256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of enhanced oxygen release from hemoglobin by RSR13 in an acute renal failure model.
    Burke TJ; Malhotra D; Shapiro JI
    Kidney Int; 2001 Oct; 60(4):1407-14. PubMed ID: 11576354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation.
    Khandelwal SR; Randad RS; Lin PS; Meng H; Pittman RN; Kontos HA; Choi SC; Abraham DJ; Schmidt-Ullrich R
    Am J Physiol; 1993 Oct; 265(4 Pt 2):H1450-3. PubMed ID: 8238433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right-shifting the oxyhemoglobin dissociation curve with RSR13: effects on high-energy phosphates and myocardial recovery after low-flow ischemia.
    Woods JA; Storey CJ; Babcock EE; Malloy CR
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):359-63. PubMed ID: 9514179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.
    Stupp R; Dietrich PY; Ostermann Kraljevic S; Pica A; Maillard I; Maeder P; Meuli R; Janzer R; Pizzolato G; Miralbell R; Porchet F; Regli L; de Tribolet N; Mirimanoff RO; Leyvraz S
    J Clin Oncol; 2002 Mar; 20(5):1375-82. PubMed ID: 11870182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector.
    Safo MK; Moure CM; Burnett JC; Joshi GS; Abraham DJ
    Protein Sci; 2001 May; 10(5):951-7. PubMed ID: 11316875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme.
    Chang SM; Lamborn KR; Malec M; Larson D; Wara W; Sneed P; Rabbitt J; Page M; Nicholas MK; Prados MD
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):353-7. PubMed ID: 15380566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efaproxiral: a novel radiation sensitiser.
    Suh JH
    Expert Opin Investig Drugs; 2004 May; 13(5):543-50. PubMed ID: 15155129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
    Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
    J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing hemoglobin oxygen affinity does not increase hydroxyl radicals after acute subdural hematoma in the rat.
    Doppenberg EM; Rice MR; Alessandri B; Qian Y; Di X; Bullock R
    J Neurotrauma; 1999 Feb; 16(2):123-33. PubMed ID: 10098957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases.
    Stea B; Shaw E; Pintér T; Hackman J; Craig M; May J; Steffen RP; Suh JH
    Br J Cancer; 2006 Jun; 94(12):1777-84. PubMed ID: 16773073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of RSR13 on microvascular Po
    Watanabe A; Poole DC; Kano Y
    J Appl Physiol (1985); 2017 Oct; 123(4):764-772. PubMed ID: 28620055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study.
    Laterra JJ; Grossman SA; Carson KA; Lesser GJ; Hochberg FH; Gilbert MR;
    Neuro Oncol; 2004 Jan; 6(1):15-20. PubMed ID: 14769135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Prodrugs as Drug Candidates for the Treatment of Ischemic Disorders: Insights into NO-Releasing Prodrug Biotransformation and Hemoglobin-NO Biochemistry.
    Xu GG; Deshpande TM; Ghatge MS; Mehta AY; Omar AS; Ahmed MH; Venitz J; Abdulmalik O; Zhang Y; Safo MK
    Biochemistry; 2015 Dec; 54(49):7178-92. PubMed ID: 26582149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
    Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.